Principles of Drug Design

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

DRUG-RECEPTOR INTERACTIONS
Lecture 7 – NPs and The Pharmaceutical Industry. Artemisinin Artemisinin treats multi-drug resistant strains of malaria. It is a sesquiterpene lactone.
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Lipinski’s rule of five
Drug Design Dr. Bilal Al-Jaidi.
Design of Small Molecule Drugs Targeted to RNA RNA Ontology Group May
Organic Chemistry 4 th Edition Paula Yurkanis Bruice Irene Lee Case Western Reserve University Cleveland, OH ©2004, Prentice Hall Chapter 30 The Organic.
Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Drug Development
Drugs from plants: * Medicinal plants have been used as a major source of drugs for thousands of years in human history, and even today they are basis.
Bioinformatics Ayesha M. Khan Spring Phylogenetic software PHYLIP l 2.
Structure-based Drug Design
Chapter 9: Making new antibiotics. Model organisms are used to speed drug discovery A model organism is a non-human species that is extensively studied.
Advanced Medicinal Chemistry
Important Points in Drug Design based on Bioinformatics Tools History of Drug/Vaccine development –Plants or Natural Product Plant and Natural products.
Molecular Descriptors
Functional groups / Pharmacological Activity
Drug Design Optimizing Target Interactions
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
Chapter 12. Target disease Priority for the Pharmaceutical Industry: Can the profits from marketing a new drug outweigh the cost of developing and testing.
New Drug Discovery From Medicinal Plants/ Natural Products Dabur Research Foundation, Sahibabad.
Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
PHAR 2133 MEDICINAL CHEMISTRY DRUGS: AN OVERVIEW Faculty of Pharmacy Cyberjaya University College of Medical Sciences.
Marine Drug Development and Delivery Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM ,
Quinoline Alkaloids In general, the alkaloids containing essentially the ‘quinoline’ nucleus include a series of alkaloids obtained exclusively from the cinchona.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
D9 Drug design Compound libraries Combinatorial and parallel chemistry
TOPICS IN (NANO) BIOTECHNOLOGY
DE NOVO DESIGN OF A THYMIDYLATE KINASE INHIBITOR.
Drug Discovery & Development
Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,
Lecture 6 II. Non-receptor Mechanisms. Direct Physical blocking of channel local anesthetic & amiloride Modulator Bind to the channel protein itself Ca.
 Receptors are mostly membrane-bound proteins that selectively bind small molecules called ligands which results in physiological response.  They are.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 9 DRUG DISCOVERY: FINDING A LEAD Part 2: Section 9.4 (Lead compounds from the natural world)
1 Biological Discovery High Volume Screening Combinatorial Diversity Structure, Design, Informatics Lead Series Biodisposition Toxicity Efficacy Pharmacokinetics.
Drug Discovery & Development PHC 311 LEC. 3 Sunday 9/ 11/ 1434H.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 10 DRUG DESIGN: OPTIMIZING TARGET INTERACTIONS Part 2: Section 10.2.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Intellectual Property Rights and Pharmaceutical Industry
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
Chapter 6. pKa & Chapter 7. Solubility
Plants and Fungi Used to Treat Infectious Disease
1 DRUG DISCOVERY Random Search e.g., buying paintbrush, mop, hammer, gluestick, nail, etc. etc. for hanging a picture frame on the wall Rational Design.
1 © 2. DRUG TARGETS Between species Antibacterial and antiviral agentsAntibacterial and antiviral agents Identify targets which are unique to the invading.
Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.
DRUG DESIGN: OPTIMIZING TARGET INTERACTIONS
Shows tendency for mergers. These big companies may be shrinking – much research is now outsourced to low cost countries like Latvia, India, China and.
Molecular Modeling in Drug Discovery: an Overview
Compounds may be altered by isosteric replacements of atoms or groups, to develop analogues with.select biological effects or to act as antagonists to.
Natural products from plants
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 9 DRUG DISCOVERY: FINDING A LEAD Part 1: Sections
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Lipinski’s rule of five
Drug Discovery &Development
Rational Drug Discovery
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Important Points in Drug Design based on Bioinformatics Tools
An Introduction to Medicinal Chemistry 3/e
Structural Bioinformatics in Drug Discovery
Rational Drug Design Dr SANTOSH MOKALE. Professor,
Virtual Screening.
Rules for Rapid Property Profiling from Structure
Innovation & the Pharmaceutical Research & Development Industry
Lixia Yao, James A. Evans, Andrey Rzhetsky  Trends in Biotechnology 
Insight into the Pharmaceutical Industry
Important Points in Drug Design based on Bioinformatics Tools
Drug Design and Drug Discovery
Chemistry of natural products
Anti-Coagulants Physical Process of Clotting
ORGANIC PHARMACEUTICAL CHEMISTRY IV
Presentation transcript:

Principles of Drug Design Full Toolbox Required for Success! Biological Discovery Biodisposition High Volume Screening Toxicity IND Lead Series Combinatorial Diversity Efficacy Rational [Structure, Design, Informatics] Pharmacokinetics Lead Discovery Iterative Preclinical Research Process R&D MEDC 603 Fall 2007

Principles of Drug Design Lipinski’s Rule of Fives MW < 500 Fewer than five H-bond donating functions Fewer than 10 H-bond accepting functions Calculated logP (ClogP) between –1 and +5 n-octanol [D]Lipid P = log P H2O [D]Water GI Tract Vasculature (after absorption) MEDC 603 Fall 2007

Principles of Drug Design Lipinski’s Rule of Fives …. Examples MW = 180 Da # H-bond donors = 1 # H-bond acceptors = 4 ClogP =2.44 Aspirin MW = 282 Da # H-bond donors = 0 # H-bond acceptors = 5 ClogP =4.15 Artemisinin MEDC 603 Fall 2007

Principles of Drug Design Lipinski’s Rule of Fives …. Examples MW = 429 Da # H-bond donors = 1 # H-bond acceptors = 3 ClogP = 4.74 RU-486 Amlodipine MW = 407.5 Da # H-bond donors = 3 # H-bond acceptors = 7 ClogP = -0.17 MEDC 603 Fall 2007

Principles of Drug Design General Approaches Pharmacophore ………an ensemble of steric and electronic features necessary to ensure the optimal supramolecular interactions with a specific biological target to trigger (or block) a biological response MEDC 603 Fall 2007

Principles of Drug Design Chemical and Biochemical Isosteres Grimm’s Hydride Displacement Law C N O F Ne CH NH OH FH CH2 NH2 OH2 CH3 NH3 Hinsberg’s Ring Equivalents Benzene, thiophene and pyridine are equivalent. e.g., H1-receptor antagonists … tripelennamine and methaphenilene MEDC 603 Fall 2007

Principles of Drug Design Chemical and Biochemical Isosteres Friedman’s Bioisosteres …. chemical and physical properties Uracil ….. Fluorouracil (antineoplastic) Salicylic acid ….. Salicamide (analgesic) Estradiol ….. Diethyl stilbestrol (estrogenic) MEDC 603 Fall 2007

Principles of Drug Design Lengthening Alkyl Chains Increase hydrophobicity, decrease water solubility Increase conformational flexibility May be directly involved in interaction with receptor Biological Activity Chain Length ‘Normal’ Behavior Morphine MEDC 603 Fall 2007

Principles of Drug Design Flexibility of Drugs and Affinity = Bound Water = Free Water DGOBS = DGComplex + DGSolv + DGConf = -RT ln K MEDC 603 Fall 2007

Principles of Drug Design Dopamine Receptor Agonist II < III < IV < I MEDC 603 Fall 2007

Natural Products General ~25% of drugs in use today are derived from natural products 61% of the 877 NCE introduced between 1981 and 2002 can be traced to a natural product origin (J. Nat. Prod. (2003) 66:1022) In certain therapeutic areas, the impact is even higher, e.g., anti-cancer (74%) and anti-bacterial (78%) Yet, natural products was de-emphasized 20 years ago because of the advent of combinatorial chemistry! Combinatorial chemistry was not only faster and cheaper, but was much clearer with respect to intellectual property rights The alarming decline in the number of NCEs in the past years from an average of 30 per year to about 17 a year is correlated with decreased interest in natural products chemistry MEDC 603 Fall 2007

Natural Products Natural products evolved for self-defense!! General Natural products evolved for self-defense!! Amazing are the natural products that apparently evolved only for the purpose of alleviating our diseases, e.g., the statins Traditionally natural products are plant products, e.g., morphine from Papaver somniferum or digitoxin from Digitalis Plants form the bulk of natural product suppliers … current estimate of number of plant species on earth is ¼ million These days natural products are obtained from plants, algae, insects, bacteria, yeast, animals, …. MEDC 603 Fall 2007

Natural Products Evolution against challenges Structural diversity Advantages of Natural Products Evolution against challenges Structural diversity ‘Apparently’ unlimited quantity Potency Disadvantages of Natural Products Synthesis Isolation Identification MEDC 603 Fall 2007

Natural Products Typically process of drug discovery from natural sources Pre-knowledge helpful (cultural folklore, Chinese Materia Medica, Indian Ayurveda, ….) Collect source (plant, algae, animals, ….) Screen extracts (organic + aqueous extractions) HIT!! Chromatographic separation Screen individual components HIT or MISS?? Structural identification Independent synthesis and re-bioassay MEDC 603 Fall 2007

Natural Products Selected Examples of Natural Product derived Drugs Digitalis purpurea (Foxglove) and Digitalis lanata … long known for their healthy heart effects … exert a positive inotropic effect on cardiac muscles … treatment for heart failure MEDC 603 Fall 2007

Natural Products Selected Examples of Natural Product derived Drugs Quinidine …bark of Cinchona tree …… anti-arrhythmic drug Quinine … no cardiac activity … anti-infective … malaria MEDC 603 Fall 2007

Natural Products Selected Examples of Natural Product derived Drugs Reserpine …… alkaloid from Rauwolfia serpentina plant … lead from the Indian Ayurvedic system as good for heart ... used as anti-hypertensive … the plant was a source of ~20 different alkaloids … MEDC 603 Fall 2007

Natural Products Selected Examples of Natural Product derived Drugs …… fungal metabolites ... first fungal metabolite was compactin which inhibited HMG-CoA reductase … compactin is isolated from Penicillium citrinum, Penicillium brevicompactin and Penicillium cyclopium ... an anti-fungal agent too, but toxic ... MEDC 603 Fall 2007

Natural Products Selected Examples of Natural Product derived Drugs Warfarin Dicoumarol Dicoumarol … … coumarin derivative … coumarin is widely distributed in nature … high concentrations in tonka beans (Dipteryx odorata) and also in Melitotus albus (sweet clover) … a hemorrhagic disorder was observed in animals that had consumed spoiled stuff composed of sweet clover … MEDC 603 Fall 2007

Natural Products Selected Examples of Natural Product derived Drugs Heparin … trying to find a coagulant ... accidentally found an anticoagulant! … structure took decades to come about … now we have low molecular weight heparin and heparin pentasaccharide … MEDC 603 Fall 2007

Natural Products V B NP NPD SNP S Overview of Natural Products as Drugs Status in the Period 1981-2002 V = vaccines B = biologicals NP = natural products NPD = natural product derivatives SNP = synthetics derived from NP S = straight synthetics V B NP NPD SNP S Compiled from : Newman, D. J., Cragg, G. M., and Snader, K. M. (2003) NATURAL PRODUCTS AS SOURCES OF NEW DRUGS OVER THE PERIOD 1981 – 2002. Journal of Natural Products 66, 1022-1037. MEDC 603 Fall 2007

Natural Products Structural Comparison between Natural Products and Combinatorial Compounds Combinatorial Compounds Data from Feher and Schmidt, J. Chem. Inf. Comput. Sci (2003) 43, 218. Statistically defined chemical space is similar for natural products and drugs, while combinatorial compounds and drugs do not share similar space. Natural Products Drugs MEDC 603 Fall 2007

Natural Products Current Efforts Nasute termites …. Soldier termites use their nozzle (squirt gun) to tangle up the invader in their toxic glue …. being developed by Entocosm, Australia as an antibiotic …. the natural product is 10 times less potent than a clinically practical antibiotic …. a potent ‘lead’ molecule Originally identified through synthesis … epoD was found to be produced by certain bacteria … genetic engineering … polyketide synthase gene knockout (epoD to epoB) … good yields … being developed by Kosan, CA as an antitumor (inhibition of microtubule formation) MEDC 603 Fall 2007